Zealand Pharma — Maj 2026
-
Zealand ekstraordinær GF - Camilla Sylvest https://proinvestor.com/boards/132185
-
Godmorgen
-
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program; Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
Robust cash position of USD 2.3 billion (DKK 14.5 billion) as of March 31, 2026
Financial strength to be further enhanced by significant milestone payments of USD 700 million from Roche in 2026 -
Zealand Pharma Announces Financial
Results for the First Three Months of 2026 https://ml-eu.globenewswire.com/Resource/Download/4b5257b4-dec6-4f8e-a57a-fed209b2b5b7 -
Zealand Pharma: Aktietilbagekøb er et stærkt signal https://proinvestor.com/boards/132238
-
Zealand Pharma sætter gang i udlodningen efter begivenhedsrigt forår https://proinvestor.com/investornyt/1441502/zealand-pharma-saetter-gang-i-udlodningen-efter-begivenhedsrigt-forar
-
OVERBLIK: Disse selskaber er shortet på det danske aktiemarked https://proinvestor.com/investornyt/1441526/overblik-disse-selskaber-er-shortet-pa-det-danske-aktiemarked
-
Dejligt at en masse shortere har brændt måsen i disse dage på Zealand
-
-
Med det seneste regnskab har Novo Nordisk slået en pæl igennem den uro og angst der har været omkring aktien. Helge Larsen kigger på regnskabet og selskabets fremtid og konkurrencesituationen med Eli Lilly. Zealand Pharma leverede et regnskab, der var som forventet - men hvad der ikke var forventet var meddelelsen om, at noget af den store kassebeholdning skal bruges på aktietilbagekøb. Kort video: https://proinvestor.com/boards/132247/
-
Zealand vil udvikle fremtidens vægttabsmidler: Mere data skal overbevise markedet https://proinvestor.com/investornyt/1441581/zealand-vil-udvikle-fremtidens-vaegttabsmidler-mere-data-skal-overbevise-markedet
-
Zealand-topchef om aktietilbagekøbsprogram: "Vi står i en unik situation" https://proinvestor.com/investornyt/1441585/zealand-topchef-om-aktietilbagekobsprogram-vi-star-i-en-unik-situation
-
Saxo om Zealand Pharma: Vigtigt at huske på investeringscasen før kursfejring https://proinvestor.com/investornyt/1441649/saxo-om-zealand-pharma-vigtigt-at-huske-pa-investeringscasen-for-kursfejring
-
Zealand Pharmas kronjuvel har førstevalgspotentiale siger topchef https://proinvestor.com/investornyt/1441553/zealand-pharmas-kronjuvel-har-forstevalgspotentiale-siger-topchef
-
Zealand Pharma: Aktietilbagekøb styrker tilliden https://proinvestor.com/boards/132256
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind